Robert E. W. Hancock
27Patents
12h-index
43Co-inventors
81Inventor score
Filing activity: Mar 13, 1995 → Feb 19, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5593866A | Cationic peptides and method for production | Chemistry; Metallurgy | 57 | Expired |
| US6191254A | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 41 | Expired |
| US6057291A | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6465429B1 | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6818407B2 | Anti-endotoxic antimicrobial cationic peptides and methods of use therfor | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5707855A | CEMA cationic peptide and polynucleotides encoding cEMA | Chemistry; Metallurgy | 20 | Expired |
| US6297215A | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6906035B2 | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5688767A | Treatment of endotoxin-associated disorders with cationic peptides | Chemistry; Metallurgy | 18 | Expired |
| US9017656B2 | Small cationic antimicrobial peptides | Emerging Cross-Sectional Technologies | 17 | Active |
| US6040435A | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6288212A | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5789377A | Treatment of endotoxin-associated disorders with cationic peptides | Chemistry; Metallurgy | 11 | Expired |
| US9061001B2 | Combination adjuvant formulation | Chemistry; Metallurgy | 11 | Active |
| US6172185A | Antimicrobial cationic peptide derivatives of bactenecin | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5877274A | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6358921B1 | Antimicrobial peptide compositions and method | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6337317B1 | Antimicrobial peptides and methods of use thereof | Human Necessities | 7 | Expired |
| US8343475B2 | Small cationic antimicrobial peptides | Emerging Cross-Sectional Technologies | 6 | Active |
| US8252737B2 | Antimicrobial peptides and methods of use | Human Necessities | 5 | Active |
| US6747007B2 | Antimicrobial peptides and methods of use thereof | Human Necessities | 4 | Expired |
| US7687454B2 | Effectors of innate immunity determination | Chemistry; Metallurgy | 3 | Active |
| US9408908B2 | Combination adjuvant formulation | Chemistry; Metallurgy | 2 | Active |
| US7507787B2 | Effectors of innate immunity | Chemistry; Metallurgy | 2 | Expired |
| US7390873B2 | Antimicrobial cationic peptides | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.